BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10494035)

  • 21. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis.
    Colucci M; Binetti BM; Branca MG; Clerici C; Morelli A; Semeraro N; Gresele P
    Hepatology; 2003 Jul; 38(1):230-7. PubMed ID: 12830006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noble-Collip Drum Trauma Induces Disseminated Intravascular Coagulation But Not Acute Coagulopathy of Trauma-Shock.
    Hayakawa M; Gando S; Ono Y; Wada T; Yanagida Y; Sawamura A; Ieko M
    Shock; 2015 Mar; 43(3):261-7. PubMed ID: 25423126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation.
    Mosnier LO; Elisen MG; Bouma BN; Meijers JC
    Thromb Haemost; 2001 Oct; 86(4):1057-64. PubMed ID: 11686324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of the postulated mechanisms linking cancer and thrombosis.
    ten Cate H; Falanga A
    Pathophysiol Haemost Thromb; 2008; 36(3-4):122-30. PubMed ID: 19176985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis.
    Mosnier LO; Meijers JC; Bouma BN
    Thromb Haemost; 2001 Oct; 86(4):1040-6. PubMed ID: 11686322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of thrombin in haemostasis.
    Al-Amer OM
    Blood Coagul Fibrinolysis; 2022 Apr; 33(3):145-148. PubMed ID: 35239615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glomerular coagulation system in renal diseases.
    Kanfer A
    Ren Fail; 1992; 14(3):407-12. PubMed ID: 1509174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis.
    Wu KK; Matijevic-Aleksic N
    Ann Med; 2000 Dec; 32 Suppl 1():73-7. PubMed ID: 11209986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA; Cox LM; Bouma BN
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coagulation and fibrinolysis in gastric cancer.
    Repetto O; De Re V
    Ann N Y Acad Sci; 2017 Sep; 1404(1):27-48. PubMed ID: 28833193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anticoagulant and fibrinolytic systems of the injured vascular endothelial cells].
    Takeya H; Suzuki K
    Rinsho Byori; 1994 Apr; 42(4):333-9. PubMed ID: 8176840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of blood coagulation factor XI in downregulation of fibrinolysis.
    Bouma BN; Meijers JC
    Curr Opin Hematol; 2000 Sep; 7(5):266-72. PubMed ID: 10961575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation, sepsis, and coagulation.
    Esmon CT; Fukudome K; Mather T; Bode W; Regan LM; Stearns-Kurosawa DJ; Kurosawa S
    Haematologica; 1999 Mar; 84(3):254-9. PubMed ID: 10189392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombin-activatable fibrinolysis inhibitor in hypothyroidism and hyperthyroxinaemia.
    Verkleij CJ; Stuijver DJ; van Zaane B; Squizzato A; Brandjes DP; Büller HR; Meijers JC; Gerdes VE
    Thromb Haemost; 2013 Feb; 109(2):214-20. PubMed ID: 23197299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The overall hemostasis potential: a laboratory tool for the investigation of global hemostasis.
    Antovic A
    Semin Thromb Hemost; 2010 Oct; 36(7):772-9. PubMed ID: 20978998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiology of blood coagulation.
    Bloom AL
    Haemostasis; 1990; 20 Suppl 1():14-29. PubMed ID: 2083865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.